Salivary biomarkers of existing periodontal disease - A cross-sectional study

被引:236
作者
Miller, CS
King, CP
Langub, C
Kryscio, RJ
Thomas, MV
机构
[1] Univ Kentucky, Coll Med, Dept Oral Hlth Practice, Oral Med Sect, Lexington, KY 40536 USA
[2] Univ Kentucky, Coll Med, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40536 USA
[3] Ctr Dis Control & Prevent, Off Publ Hlth Res, Atlanta, GA USA
[4] Univ Kentucky, Coll Publ Hlth, Dept Biostat, Lexington, KY 40506 USA
[5] Univ Kentucky, Coll Arts & Sci, Dept Stat, Lexington, KY 40506 USA
关键词
periodontal disease; saliva; biomarkers; interleukin-1; beta; matrix metalloproteinase;
D O I
10.14219/jada.archive.2006.0181
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background. The authors conducted a study to determine if salivary biomarkers specific for three aspects of periodontitis-inflammation, collagen degradation and bone turnover-correlate with clinical features of periodontal disease. Methods. The relationship between periodontal disease and the levels of interleukin-1 beta (IL-1 beta), matrix metalloproteinase (MMP)-8, and osteoprotegerin (OPG) in whole saliva of 57 adults (28 "case" subjects with moderate-to-severe periodontal disease and 29 healthy control subjects) was examined in a case-control trial. Results. Mean levels of IL-1 beta and MMP-8 in saliva were significantly higher in case subjects than in controls. Both analytes correlated with periodontal indexes, whereas, after adjustment for confounders, OPG did not. Elevated salivary levels of MMP-8 or IL-1 beta (more than two standard deviations above the mean of the controls) significantly increased the risk of periodontal disease (odds ratios in the 11.3-15.4 range). Combined elevated salivary levels of MMP-8 and II-1 beta increased the risk of experiencing periodontal disease 45-fold, and elevations in all three biomarkers correlated with individual clinical parameters indicative of periodontal disease. Conclusion. Salivary levels of MMP-8 and IL-1 beta appear to serve as biomarkers of periodontitis. Clinical Implications. Qualitative changes in the composition of salivary biomarkers could have significance in the diagnosis and treatment of periodontal disease.
引用
收藏
页码:322 / 329
页数:8
相关论文
共 66 条
[1]   Interleukin-1 beta, prostaglandin E(2), and immunoglobulin G subclasses in gingival crevicular fluid in patients undergoing periodontal therapy [J].
Alexander, DCC ;
Martin, JC ;
King, PJ ;
Powell, JR ;
Caves, J ;
Cohen, ME .
JOURNAL OF PERIODONTOLOGY, 1996, 67 (08) :755-762
[2]  
Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1
[3]   Periodontal diagnoses and classification of periodontal diseases [J].
Armitage, GC .
PERIODONTOLOGY 2000, 2004, 34 :9-21
[4]  
Armitage GC, 2003, J PERIODONTOL, V74, P1237, DOI 10.1902/jop.2003.74.8.1237
[5]   Treatment with subantimicrobial dose doxycycline improves the efficacy of scaling and root planing in patients with adult periodontitis [J].
Caton, JG ;
Ciancio, SG ;
Blieden, TM ;
Bradshaw, M ;
Crout, RJ ;
Hefti, AF ;
Massaro, JM ;
Polson, AM ;
Thomas, J ;
Walker, C .
JOURNAL OF PERIODONTOLOGY, 2000, 71 (04) :521-532
[6]   Subantimicrobial dose doxycycline as an adjunct to scaling and root planing: post-treatment effects [J].
Caton, JG ;
Ciancio, SG ;
Blieden, TM ;
Bradshaw, M ;
Crout, RJ ;
Hefti, AF ;
Massaro, JM ;
Polson, AM ;
Thomas, J ;
Walker, C .
JOURNAL OF CLINICAL PERIODONTOLOGY, 2001, 28 (08) :782-789
[7]   Metabolic and bone effects after administration of ipriflavone and salmon calcitonin in postmenopausal osteoporosis [J].
Cecchettin, M ;
Bellometti, S ;
Cremonesi, G ;
Solimeno, LP ;
Torri, G .
BIOMEDICINE & PHARMACOTHERAPY, 1995, 49 (10) :465-468
[8]   Application of microchip assay system for the measurement of C-reactive protein in human saliva [J].
Christodoulides, N ;
Mohanty, S ;
Miller, CS ;
Langub, MC ;
Floriano, PN ;
Dharshan, P ;
Ali, MF ;
Bernard, B ;
Romanovicz, D ;
Anslyn, E ;
Fox, PC ;
McDevitt, JT .
LAB ON A CHIP, 2005, 5 (03) :261-269
[9]   Salivary matrix metalloproteinase (MMP-8) levels and gelatinase (MMP-9) activities in patients with type 2 diabetes mellitus [J].
Collin, HL ;
Sorsa, T ;
Meurman, JH ;
Niskanen, L ;
Salo, T ;
Rönka, H ;
Konttinen, YT ;
Koivisto, AM ;
Uusitupa, M .
JOURNAL OF PERIODONTAL RESEARCH, 2000, 35 (05) :259-265
[10]  
DAWES C, 1974, International Journal of Chronobiology, V2, P253